Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
Publication date
2020-08-13
Authors
van de Veerdonk, Frank L
Kouijzer, Ilse J E
de Nooijer, Aline H
van der Hoeven, Hans G
Maas, Coen
Netea, Mihai G
Brüggemann, Roger J M
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
Abstract
Keywords
Adult, Aged, Betacoronavirus, Bradykinin B2 Receptor Antagonists/therapeutic use, Bradykinin/analogs & derivatives, Coronavirus Infections/drug therapy, Female, Humans, Male, Middle Aged, Oxygen/blood, Pandemics, Pneumonia, Viral/drug therapy, Receptor, Bradykinin B2/metabolism, Journal Article
Citation
van de Veerdonk, F L, Kouijzer, I J E, de Nooijer, A H, van der Hoeven, H G, Maas, C, Netea, M G & Brüggemann, R J M 2020, 'Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19', JAMA network open, vol. 3, no. 8, e2017708. https://doi.org/10.1001/jamanetworkopen.2020.17708